Alternative Conversion Methods for Transition Probabilities in State-Transition Models: Validity and Impact on Comparative Effectiveness and Cost-Effectiveness

被引:1
|
作者
Jahn, Beate [1 ]
Kurzthaler, Christina [1 ,2 ]
Chhatwal, Jagpreet [3 ,4 ]
Elbasha, Elamin H. [5 ]
Conrads-Frank, Annette [1 ]
Rochau, Ursula [1 ]
Sroczynski, Gaby [1 ]
Urach, Christoph [6 ]
Bundo, Marvin [1 ]
Popper, Niki [6 ,7 ,8 ]
Siebert, Uwe [1 ,3 ,4 ,9 ]
机构
[1] UMIT Univ Hlth Sci Med Informat & Technol, Inst Publ Hlth Med Decis Making & Hlth Technol As, Dept Publ Hlth Hlth Serv Res & Hlth Technol Asses, Hall In Tirol, Austria
[2] Univ Innsbruck, Inst Theoret Phys, Innsbruck, Austria
[3] Harvard Med Sch, Inst Technol Assessment, Massachusetts Gen Hosp, Boston, MA 02115 USA
[4] Harvard Med Sch, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA
[5] Merck & Co Inc, Kenilworth, NJ USA
[6] Dwh GmbH Simulat Serv & Tech Solut, Vienna, Austria
[7] Tech Univ, Inst Anal & Sci Comp, Vienna, Austria
[8] DEXHELPP Decis Support Hlth Policy & Planning, Vienna, Austria
[9] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, Boston, MA USA
关键词
conversion transition probability; cost-effectiveness analysis; markov model; markov transition matrix; state-transition model; MARKOV-CHAIN; MATRICES; RATES;
D O I
10.1177/0272989X19851095
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background. In state-transition models (STMs), decision problems are conceptualized using health states and transitions among those health states after predefined time cycles. The naive, commonly applied method (C) for cycle length conversion transforms all transition probabilities separately. In STMs with more than 2 health states, this method is not accurate. Therefore, we aim to describe and compare the performance of method C with that of alternative matrix transformation methods. Design. We compare 2 alternative matrix transformation methods (Eigenvalue method [E], Schure-Pade method [SP]) to method C applied in an STM of 3 different treatment strategies for women with breast cancer. We convert the given annual transition matrix into a monthly-cycle matrix and evaluate induced transformation errors for the transition matrices and the long-term outcomes: life years, quality-adjusted life-years, costs and incremental cost-effectiveness ratios, and the performance related to the decisions. In addition, we applied these transformation methods to randomly generated annual transition matrices with 4, 7, 10, and 20 health states. Results. In theory, there is no generally applicable correct transformation method. Based on our simulations, SP resulted in the smallest transformation-induced discrepancies for generated annual transition matrices for 2 treatment strategies. E showed slightly smaller discrepancies than SP in the strategy, where one of the direct transitions between health states was excluded. For long-term outcomes, the largest discrepancy occurred for estimated costs applying method C. For higher dimensional models, E performs best. Conclusions. In our modeling examples, matrix transformations (E, SP) perform better than transforming all transition probabilities separately (C). Transition probabilities based on alternative conversion methods should therefore be applied in sensitivity analyses.
引用
收藏
页码:509 / 522
页数:14
相关论文
共 50 条
  • [31] Comparative Effectiveness and Cost-Effectiveness Analysis of a Urine Test versus Alternative Colorectal Cancer Screening Strategies
    Barichello, Scott
    Thanh Nguyen
    Deng, Lu
    Ismond, Kathleen P.
    Loomes, Dustin E.
    Kirwin, Erin
    Wang, Haili
    Chang, David
    Svenson, Larry
    Fedorak, Richard N.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S153 - S153
  • [32] Pharmacoeconomics of long-acting risperidone: Results and validity of cost-effectiveness models
    Haycox, A
    PHARMACOECONOMICS, 2005, 23 (Suppl 1) : 3 - 16
  • [33] Pharmacoeconomics of long-acting risperidone: Results and validity of cost-effectiveness models
    Alan Haycox
    PharmacoEconomics, 2005, 23 : 3 - 16
  • [34] Assessing the Cost-Effectiveness of Incentives for Energy Transition Using Marginal Abatement Cost Curves
    Billi, Sofia
    Prina, Matteo Giacomo
    Castagna, Marco
    Sparber, Wolfram
    ENERGIES, 2023, 16 (21)
  • [35] THE IMPACT OF TREATMENT COEFFICIENT PARAMETERIZATION FOR MIXTURE CURE MODELS ON COST-EFFECTIVENESS MODELS
    Al-Khayat, Z.
    Vincken, T.
    Verhoek, A.
    Heeg, B.
    Ouwens, M.
    VALUE IN HEALTH, 2022, 25 (01) : S210 - S210
  • [36] COMPARING FIVE ALTERNATIVE METHODS OF BREAST RECONSTRUCTION SURGERY: A COST-EFFECTIVENESS ANALYSIS
    Padula, W., V
    Grover, R.
    Van Vliet, M.
    Ridgway, E. B.
    VALUE IN HEALTH, 2014, 17 (03) : A88 - A88
  • [37] Comparing live Alternative Methods of Breast Reconstruction Surgery: A Cost-Effectiveness Analysis
    Grover, Ritwik
    Padula, William V.
    Van Vliet, Michael
    Ridgway, Emily B.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2013, 132 (05) : 709E - 723E
  • [38] The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study
    Leal, Jose
    Manetti, Stefania
    Buchanan, James
    PHARMACOECONOMICS, 2018, 36 (10) : 1263 - 1272
  • [39] The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study
    José Leal
    Stefania Manetti
    James Buchanan
    PharmacoEconomics, 2018, 36 : 1263 - 1272
  • [40] Matching the model with the evidence: comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patients
    Degeling, Koen
    Franken, Mira D.
    May, Anne M.
    van Oijen, Martijn G. H.
    Koopman, Miriam
    Punt, Cornelis J. A.
    Ijzerman, Maarten J.
    Koffijberg, Hendrik
    CANCER EPIDEMIOLOGY, 2018, 57 : 60 - 67